ARSB and melanoma: Treatment with rhARSB or by ARSB siRNA in A375 melanoma cells impacts cytokine production (unpublished data), suggesting that inflammatory mechanisms may also contribute to the rhARSB-induced enhancement of apoptosis and to other pathways of cell death.